FABP3 and angina pectoris: Furthermore, our previous studies found that plasma FABP3 could be used as a surrogate for reduced ejection fraction and abnormal corrected QT (QTc) interval, and that in patients with stable angina (21), plasma FABP4 level may also be associated with an abnormal QTc interval (22).